Skip to main content

Full text of "Cannabinoid Research Society Symposium 2012"

See other formats


22^ ANNUAL 

SYMPOSIUM OF THE 

INTERNATIONAL CANNABINOID 
RESEARCH SOCIETY 



FREIBURG 

JULY 22 - 27, 2012 



PRELIMINARY PROGRAMME 

(SUBJECT TO CHANGES) 



REGISTRATION: JULY 22 nd , 2012 (16.00-19.00) 
WELCOME RECEPTION: 18.30-20.00 



DAY 1 

Monday, July 23 rd 



7.30 


Breakfast 


8.30 


Welcome and Opening Remarks 


Oral Session 1. Neurodegeneration 

Chairs: David Baker and Javier Fernandez- Ruiz t,*^^ 

PAGE # 


8.45 


Daniel K. Nomura, 
Tarek A. Samad 
and Benjamin F. Cravatt 


ENDOCANNABINOID HYDROLYSIS 
GENERATES BRAIN PROSTAGLANDINS 
THAT PROMOTE 
NEUROINFLAMMATION 


1 


9.00 


Scott D. Smid 
and Jesper L.V. Maag 


CANNABINOID LIGANDS DIRECTLY 
MODIFY P- AMYLOID FIBRIL 
FORMATION AND ARE VARIABLY 
NEUROPROTECTIVE IN VITRO 


2 


9.15 


Anne-Caroline Schmole, 
Daniele Bano, 
Pierluigi Nicotera, 
Andreas Zimmer 
and Judith Alferink 


THE ROLE OF THE 
ENDOCANNABINOID RECEPTOR 
CB2 IN NEURODEGENERATION 


3 


9.30 


Ryan Graves, 
Gareth Pryce, 
Michaela Egertova, 
Benjamin F. Cravatt, Gavin 

Giovannoni, Gregory J. 
Michael, Maurice R. Elphick 
and David Baker 


EFFECTS OF GENETIC DELETION AND 
PHARMACOLOGICAL INHIBITION OF 
FATTY ACID AMIDE HYDROLASE IN 
EXPERIMENTAL AUTOIMMUNE 
ENCEPHALOMYELITIS 


4 



9.45 


Nephi Stella 


TARGETING CB1 RECEPTORS 
AND ABHD6 TO TREAT 
R6/2 MICE SYMPTOMS 


5 


10.00 


Sara Valdeolivas, 
Onintza Sagredo, Justo 
Garcia de Yebenes, Julian 
Romero, Roger Pertwee, 
Manuel Guzman and 
Javier Fernandez-Ruiz 


PHYTOCANNABINOID-BASED 
MEDICINES AS DISEASE-MODIFYING 
AGENTS IN HUNTINGTON'S DISEASE 


6 


10.15 


Jacqueline L. Blankman, 

Jonathan Z. Long 
and Benjamin F. Cravatt 


GENERATION AND 
CHARACTERIZATION OF 
ABHD12-/- MICE, A MODEL OF THE 
NEURODEGENERATIVE DISEASE 
PHARC 


7 


10.30 


Coffee Break 


Oral Session 2. Metabolic Regulation / cardiovascular 

Chairs-. George Kunos and Matthew Hill 


11.00 


George Kunos, Yossi 
Tarn, Resat Cinar, 
Jeih-San Liow, 
Robert Innis, 
Robert Chorvat 
and John F. McElroy 


PERIPHERAL CB1R INVERSE AGONISM 
REDUCES DIET-INDUCED OBESITY BY 
REVERSING LEPTIN RESISTANCE 


8 


11.15 


Matthew N. Hill, Nicole 
P. Bowles, Tiffany T. Lee 
Cecilia J. Hillard 
and Bruce S. McEwen 


ACTIVATION OF HYPOTHALAMIC 
FATTY ACID AMIDE HYDROLASE BY 
LEPTIN: REGULATION OF FOOD 
INTAKE AND EFFECTS OF 
DIET-INDUCED OBESITY 


9 


11.30 


Susan Krzysik-Walker, 
Isabel Gonzalez- 
Mariscal, Morten 
Scheibye-Knudsen, 

Fred Indig 
and Michel Bernier 


THE CANNABINOID RECEPTOR 
INVERSE AGONIST AM251 
ALTERS MITOCHONDRIAL 

PHYSIOLOGY VIA PROTEOLYTIC 
DEGRADATON OF ERRct 


10 



11.45 


A J Wheal, M D Randall 
and S E O'Sullivan 


CANNABIDIOL IMPROVES IMPAIRED 
ENDOTHELIAL FUNCTION IN 
FEMORAL ARTERIES FROM 
ZUCKER DIABETIC RATS 


11 


12.00 


William H Hind 
and Saoirse E O'Sullivan 


THE EFFECTS OF ANAND AMIDE 
ON PERMEABILITY IN 
A CELL CULTURE MODEL 
OF THE BLOOD-BRAIN BARRIER 


12 


12.15 


Sabina Adhikary, 
Hongbo Li, Mario 
Skarica, Weimin Kong, 
Anu Mahadevan, Doina 
Ganea and Ronald Tuma 


MODULATION OF INFLAMMATORY 
CELL INVASION OF THE CNS 
BY A CANNABINOID-2 SELECTIVE 
AGONIST AFTER INJURY 


13 


12.30-14.00 


LUNCH 


Oral Session 3. psychiatric diseases / learning & memory 

Chairs-. Beat Lutz and Sara Jane Ward 


14.00 


Eti Ganon-Elazar 
and Irit Akirav 


CANNABINOIDS PREVENT THE 
DEVELOPMENT OF POST-TRAUMA 
SYMPTOMS IN A RAT MODEL OF PTSD 


14 


14.15 


Ozge Gunduz-Cinar, Caitlin 
M Schaapveld, Kathryn P. 
MacPherson, Resat Cinar, 

Joyonna Gamble- 
George, Karen Sugden, 
Benjamin Williams, 
Grzegorz Godlewski, Teniel 
S Ramikie, Adam X. Gorka, 
Shakiru O. Alapafuja, 
Spyros P. Nikas, 
Alexandras Makriyannis, 
Richie Poulton, Sachin 
Patel, Ahmad R. Hariri, 
Avshalom Caspi, Terrie E. 
Moffitt, George Kunos 
and Andrew Holmes 


ANAND AMIDE IN AMYGDALA- 
MEDIATED FEAR EXTINCTION, THREAT 
PROCESSING AND STRESS-REACTIVITY: 
A TRANSLATIONAL STUDY 


15 


14.30 


Ilya Reznik 


MEDICAL CANNABIS/MARIJUANA USE 
IN POST-TRAUMATIC STRESS 
DISORDER: A LONGITUDINAL 
FOLLOW-UP STUDY 


16 



14.45 


Moriah Iverson 
and Cecilia J. Hillard 


ANXIOGENIC-LIKE EFFECT OF 
THC is lost IN MICE LACKING 
BETA-ARRESTIN-2: EVIDENCE 
FOR SEX-DEPENDENT EFFECTS 


17 


15.00 


Daniela Hauer, Piray 
Atsak, Raquel V. Fornari, 
Patrizia Campolongo, 

Gustav Schelling 
and Benno Roozendaal 


T'TV [ T ~*\ / — X / — • A TV TTV T A 11 1 \ [ / — "\ I T ~\ 

ENDOCANNABINOID- 
GLUCOCORTICOID INTERACTION IN 

THE BASOLATERAL AMYGDALA 
DURING MEMORY CONSOLIDATION 


18 


15.15 


Maria Morena, 
Viviana Trezza, 
Sergio Scaccianoce, 
Alessandro Pasquale, 
Vincenzo Cuomo, 
Gustav Schelling, 
Benno Roozendaal 
and Patrizia 
Campolongo 


CANNABINOIDS MODULATION OF 
OBJECT RECOGNITION MEMORY IN 
RATS: INVOLVEMENT OF THE 
GLUCOCORTICOID SYSTEM 


19 


15.30 


Xiang-Qun Xie, Rentian 
Feng, Peng Yang, Junpei 
Teramachi, Qin Tong, 
Lirong Wang, Zhaojun 
Xie, Kyaw Myint, 
Noriyoshi Kurihara 
and David G. Roodman 


CANNABINOID RECEPTOR CB2. 
A NEW DRUG TARGET FOR 
MULTIPLE MYELOMA INTERVENTION 


20 


15.45-17.45 


Poster Session l 
Coffee 


PI 


18.00 


Presidential Plenary Speaker 

"Planning research for the next half a century" 
RAPHAEL MECHOULAM, PH.D. 

Institute for Drug Research 
Hebrew University of Jerusalem 



Day 2 
Tuesday, July 24 th 



7.30 


Breakfast 


ORAL SESSION 4. RECEPTOR SIGNALING 

Chairs: Heather Bradshaw and MaryAbood 


8.30 


Mark Bauer, 
Andrea Chicca, Stefanie 

Hofer-Reyes, Marco 
Tamborrini, David Eisen, 
Oliver Poetz, 
Gerd Pluschke 
and Jiirg Gertsch 


IDENTIFICATION OF A FAMILY OF 
PEPTIDE ENDOCANNABINOIDS 
(PEPCANS): EVIDENCE FOR 
ALLOSTERIC MODULATION 
OF CB1 RECEPTORS 


21 


8.45 


Maria Grazia Cascio, 

Daniele Bolognini 
and Roger G. Pertwee 


Irlt LDl Ktii„til 1UK ALLU5 1 EKrC 

MODULATOR, ORG 27569, 
HAS DIFFERENT EFFECTS ON THE 
POTENCIES WITH WHICH CP55940, 
O-2050 AND SR141716A DISPLACE 
[3H]CP55940 OR [3H]SR141716A 
FROM MOUSE BRAIN CB1 RECEPTORS 


22 


9.00 


Derek M. Shore, Dow P. 
Hurst, Herb Seltzman, 
Gemma Baillie, 
Ruth Ross, Jahan P. 
Marcu, Mary Abood 
and Patricia H. Reggio 


IDENTIFICATION OF THE ORG27569 
BINDING SITE AT THE CB1 RECEPTOR: 
IMPORTANCE OF K3.28 INTERACTION 

TO THE ORG27569 EFFECT ON BASAL 
SIGNALING 


23 


9.15 


Michelle Glass, 
Erin Cawston, Courtney 
Breen, William Redmond 
and Mark Connor 


ALLOSTERIC MODULATION OF 
HUMAN CB1 RECEPTORS 


24 


9.30 


Eugen Brailoiu, 
G. Cristina Brailiou, 
Elena Deliu, 
Haleli Sharir, 
Pingwei Zhao 
and Mary E. Abood 


FUNCTIONAL INTRACELLULAR 
CANNABINOID RECEPTORS 


25 



9.45 


Lawrence C. Blume, 
Caroline E. Bass, 
George D. Dalton, 
Dana E. Selley 
and Allyn C. Howlett 


CANNABINOID RECEPTOR 
INTERACTING PROTEIN (CRIP1A) 
MODULATES CB1 RECEPTOR 
TRAFFICKING, ACTIVITY 
AND SIGNALING 


26 


10.00 


1\ a Idol la 1_ Vji 111 Lacy, 

Duneeshya Gunasekara, 

Erin Cawston, 
Catherine E Goodfellow 
and Michelle Glass 


UNUSUAL TRAFFICKING OF 
CANNABINOID RECEPTOR 2: 
AGONIST-INDUCED UPREGULATION 
OF SURFACE RECEPTORS 


27 


10.15 


Heather B. Bradshaw, 

Siham Raboune 
and Jordyn M. Stuart 


71 MDVFT NT ATYT AMinPS 

INCLUDING N-DOCOSAHEXEANOYL 
ETHANOLAMINE, HAVE ACTIVITY AT 
TRPV1-4 THE PUTATIVE IONOTROPIC 
CANNABINOID RECEPTORS 


28 


10.30 


Christopher J. Fowler, 
Peter Hammarsten and 
Mariateresa Cipriano 


ASSOCIATION BETWEEN TUMOUR 
PAKT AND CB1 RECEPTOR EXPRESSION 
IN PROSTATE CANCER 


29 


10.45 


Coffee Break 


Oral Session 5. gastrointestinal regulation 

Chairs-. Steven Kinsey and Mario van der Stelt 


11.00 


Steven G. Kinsey, 
Erica C. Cole 
and Aron H. Lichtman 


REMARKABLE POTENCY OF A'-THC IN 
BLOCKING GASTRIC HEMORRHAGES 
CAUSED BY CYCLOOXYGENASE 
INHIBITION IN MICE 


30 


11.15 


Mohammad Bashashati, 
Yasmin Nasser, Catherine 

M. Keenan, Winnie Ho, 
Fabiana Piscitelli, Giorgio 
Ortar, Ken Mackie, 

Martin A. Storr, 
Vincenzo Di Marzo 
and Keith A. Sharkey 


THE LOCALIZATION AND FUNCTION 
OF DIACYLGLYCEROL 
LIPASE (DAGL) IN THE 
GASTROINTESTINAL TRACT 


31 


11.30 


Luan Koay, Rachael 
Rigby and Karen Wright 


CANNABIDIOL INDUCES NON- 
CANONICAL AUTOPHAGY 


32 



11.45 


kang Tsou Memorial Lecture 

"DO DIFFERENTIATED NEURONS MIGRATE?" 

Michael Frotscher, M.D. 

Institute for Structural Neurobiology 
Center for Molecular Neurobiology (ZMNH) 
Universitatsklinikum Hamburg-Eppendorf (LIKE) 
Hamburg 


12.45-14.00 


NIDA Trainee Lunch and Learn 

"Cannabinoid Pharmaceutics: 
Historical Influences on Millennial Research" 

John McPartland and Allyn Howlett 


12.45-14.00 


Lunch 


Oral Session 6. PAIN 

Chairs-. Katarzyna Starowicz and Andrea Hohmann 


14.00 


Katarzyna Starowicz, 
Wioletta Makuch, 
Michal Korostynski, 
Michal Slezak, 
Magdalena Zychowska, 

Stefania Petrosino, 
Luciano De Petrocellis, 
Luigia Cristino, Barbara 

Przewlocka 
and Vincenzo Di Marzo 


full inhibition of spinal fatty 
acid amide hydrolase in 
neuropathic rats leads to trpvi- 
mediated analgesic effects via 
remodeling of the 
endocannabinoid system 


33 


14.15 


K. Starowicz, N. Malek, 
M. Mrugala, W. Makuch, 
Francesca Comelli, 
G. Ortar, E. Morera, 
B. Costa, B. Przewlocka 
and V. Di Marzo 


omdm198, a compound 
targeting both trpvi and fatty 
acid amide hydrolase: a new 
pain management strategy in 
osteoarthritis? 


34 



14.30 


James P Pearson, 
Sylvie Bernier, Carlotta 
Jackson, James D 
Wakefield, Kristie A 
Sykes, Elaine Liong, 
Galen Carey, Robert W 
Busby, Mark G Currie, 
Aron H Lichtman, 

G Todd Milne 
and Albert T Profy 


ORAL TREATMENT WITH THE 
SELECTIVE FAAH INHIBITOR 
MM-433593 RELIEVES THERMAL 
HYPERALGESIA INDUCED 
BY E. COLI LIPOPOLYSACCHARIDE 

IN C57BLACK6/J MICE 
VIA CANNABINOID CB1 RECEPTOR 


35 


14.45 


Andrew J. Kwilasz, 
Aron Lichtman 
and Steve Negus 


THE FAAH INHIBITORS PF3845 AND 
URB597 PRODUCE DISTINCT EFFECTS 
ON ACUTE PAIN-STIMULATED AND 
PAIN-DEPRESSED BEHAVIOR IN RATS 


36 


15.00 


Mauro Dionisi, 
Cataldo Martucci, 
Glauco Tarozzo, 
Rosalia Bertorelli, 
Angelo Reggiani 
and Daniele Piomelli 


A NOVEL NAAA INHIBITOR 
REVERSED UVB-INDUCED 
INFLAMMATORY RESPONSE 
BOTH IN VITRO AND IN VIVO 


37 


15.15 


Bogna M. Ignatowska- 
Jankowska, Sudeshna 
Gosh, Micah J. Niphakis, 

Scott O Neal, 
D. Matthew Walentiny, 
Jenny L. Wiley, 
Benjamin F. Cravatt, 
and Aron H. Lichtman 


THE SELECTIVE MONOACYLGLYCEROL 
LIPASE INHIBITOR KML29 PRODUCES 
ANTINOCICEPTION IN THE ABSENCE 
OF CANNABIMIMETIC EFFECTS 


38 


15.30 


Herbert H. Seltzman, 
Craig Shiner, Erin Hirt, 
Anne F. Gilliam, 
Rangan Maitra, 
Rodney W. Snyder, 
Yatendra Mulpuri and 
Igor Spigelman 


PERIPHERALLY RESTRICTED 
CB1 AGONISTS FOR 
TREATMENT OF NEUROPATHIC PAIN 


39 


15.45 


James Burston, 
Devi Sagar, Stephen 
Woodhams, Gareth 
Hathway, Emma King, 
Andrew Bennett, 
David Kendall 
and Victoria Chapman 


EVIDENCE THAT CANNABINOID CB2 
RECEPTORS PLAY A NOVEL ROLE IN 
THE MODULATION OF SPINAL 
HYPERSENSITIVITY AND PAIN 
BEHAVIOUR IN THE RAT MIA MODEL 
OF OSTEOARTHRITIS 


40 



16.00-18.00 


POSTER SESSION 2 
Coffee 


P2 


ORAL SESSION 7. PHYTOCANNABINOIDS 

Chairs: Mahmoud ElSohlyand Barbara Costa 


18.00 


Jonathan E. Page, 
Harm van Bakel, Jake Stout 
and Timothy R. Hughes 


GENOMIC ANALYSIS OF 
PHYTOCANNABINOID 
BIOSYNTHESIS IN 
CANNABIS SATIVA L. 


41 


18.15 


Michelle Sexton, 
Eiron Cudaback, 
Rehab A. Abdullah 
and Nephi Stella 


CANNABIS USE AS A 
COMPLEMENTARY 
ALTERNATIVE MEDICINE IN 

MULTIPLE SCLEROSIS: 
EFFECTS ON SOME IMMUNE 
PARAMETERS 


42 


18.30 


Daniele Bolognini, 
Erin M. Rock, 
Maria Grazia Cascio, 

Linda Parker 
and Roger G. Pertwee 


C ANNABEL) FOLIC ACID 
BEHAVES AS A HIGHLY 
POTENT ENHANCER OF 

C I I T 1 A T)T ." 'T |yi7 \ T ) 

5-rlt tA KbCbl 1UK 
ACTIVATION BOTH IN VITRO 
AND IN VIVO 


43 


18.45 


Francesca Comelli, 
Giulia Filippi, 
Elena Papaleo, 
Luca De Gioia, 
Roger Pertwee 

and Barbara Costa 


EVIDENCE THAT THE 
PHYTOCANNABINOID 
CANNABIGEROL CAN 
INDUCE ANTINOCICEPTION 
BY ACTIVATING 
a2-ADRENORECEPTORS: A 
COMPUTATIONAL AND A 
PHARMACOLOGICAL STUDY 


44 


19.00 


Istvan Ujvary, Alessia Ligresti, 
Rosaria Villano, 
Marco Allara 
and Vincenzo Di Marzo 


YANGONIN, A 
KAVALACTONE FROM 
PIPER METHYSTICUM, 
IS A NOVEL CB1 
RECEPTOR LIGAND 


45 



Day 3 

Wednesday, July 25 th 



7.30 


Breakfast 


Oral Session 8. Drug addiction 

Chairs-. Tiziana Rubino and Iain McGregor 


8.30 


Ryan Vandrey, 
Maxine L. Stitzer, 
Miriam Z. Mintzer, 
Marilyn A. Huestis, 
Jeannie A. Murray 
and Dayong Lee 


THE DOSE EFFECTS OF 
DRONABINOL (ORAL THC) 
IN HEAVY CANNABIS USERS 


46 


8.45 


Margaret Haney, Gillinder 
Bedi, Ziva D. Cooper, 

and Richard W. Foltin 


PREDICTORS OF MARIJUANA 
RELAPSE: ROBUST IMPACT OF 
CIGARETTE SMOKING 


47 


9.00 


Matthew W. Buczynski, 
Tlham Y Poll's 
and Loren H. Parsons 


THE VOLITIONAL NATURE OF 
NICOTINE EXPOSURE 
DIFFERENTIALLY ALTERS 
ANANDAMIDE AND 
OLEOYLETHANOLAMIDE LEVELS IN 
THE VENTRAL TEGMENTAL AREA 


48 


9.15 


Iain S. McGregor, Kirily 
Keats, Alex Wong, 
Kieron Rooney and 
Jonathon C. Arnold 


A 9 -THC "REINTOXICATION" EFFECTS 
IN RATS AND HUMANS 


49 


9.30 


Brian F. Thomas, Poonam 

G. Pande, Richard C. 
Daw, Kenneth H. Davis, 

Jenny L. Wiley 
and Megan E. Grabenauer 


ANALYSIS OF SMOKE 
COMPOSITION FROM PRODUCTS 
CONTAINING SYNTHETIC 
CANNABINOIDS 


50 


9.45 


Jenny L. Wiley, 
Timothy W. Lefever 
and Julie A. Marusich 


PHARMACOLOGICAL PROFILE OF 

ABUSED INDOLE-DERIVED 
CANNABINOIDS CONTAINED IN 
'HERBAL INCENSE' IN MICE 


51 



10.00 


Miriam Schneider, 
Chris M. Friemel 
and Andreas Zimmer 


HEDONIC REWARD PROCESSING 
IS ATTENUATED IN CB1 RECEPTOR 
KNOCKOUT MICE 


52 


10.15 


McMahon LR, Hruba L, 
Kinsey SG, O'Neal ST, 
Cravatt BF 
and Lichtman AH 


COMBINED EFFECTS OF A 
MONOACYLGLYCEROL LIPASE AND 

FATTY ACID AMIDE HYDROLASE 
INHIBITOR IN MICE DISCRIMINATING 
A 9 -TETRAHYDROCANNABINOL 


53 


10.30 


Zheng-Xiong Xi, Xiao- 
Qing Peng, Xia Li, Hong- 
Ju Yang, Jie Li 
and Eliot L. Gardner 


CANNABINOID CB2 RECEPTORS 

MODULATE COCAINE 
SELF- ADMINISTRATION IN RATS 


54 


10.45-12:45 


POSTER SESSION 3 
Coffee 


P3 


12.45 


Lunch 


14.00 


Excursion to the Black forest 



NOTES: 



Day 4 
Thursday, July 26 th 



7.30 


Breakfast 


8.20 


NIDA Symposium 

Role of Cannabinoid System 
in Nicotine Addiction 

ORGANIZERS: VlSHNUDUTT PUROHIT AND RAO RAPAKA 
DISCUSSANTS: BEN CRAVATT AND ARON LlCHTMAN 


8.30 


Sherry Niessen 
Scripps Research Institute 
La Jolla, CA USA 


PROTEOMICS OF 
NICOTINE-DEPENDENT BRAIN 


8.55 


Daniele Piomelli 

University of California 
Irvine, CA USA 


FAAH INHIBITORS AS POTENTIAL 
LEADS FOR SMOKING CESSATION 


9.20 


Aron Lichtman 

Virginia Commonwealth University 
Richmond, VA USA 


MODULATING NICOTINE REWARD 
AND DEPENDENCE THROUGH THE 
ENDOGENOUS CANNABINOID SYSTEM 


9.45 


Rafael Maldonado 

Universitat Pompeu Fabra 
Barcelona, Spain 


TARGETING THE CB1 RECEPTOR TO 
TREAT NICOTINE ADDICTION 


10.10 


COMMENTARY AND DISCUSSION 


10.35 


Coffee Break 


11.00 


YOUNG INVESTIGATOR AWARDEE SPEAKER 

"Interplay of endocannabinoids and plant derived 
cannabinoids with inflammation, oxidative stress and cell 
death: implications for tissue injury and protection" 

PAL PACHER, M.D., PH.D. 

Laboratory of Physiological Studies 
National Institute on Alcohol Abuse and Alcoholism, 
Bethesda,MD USA 



12.00 


Lunch 


Oral Session 9. endocannabinoid synthesis / catabolism 

Chairs: Daniel Nomura and Natsuo Ueda 


13.15 


Torn Uyama, Natsuki 
Ikematsu, Manami Inoue, 
Naoki Shinohara, Xing- 
Hua Jin, Kazuhito Tsuboi, 
Takeharu Tonai, 
Akira Tokumura 
and Natsuo Ueda 


GENERATION OF N- 
ACYLPHOSPHATIDYLETHANOLAMINE 
BY MEMBERS OF PHOSPHOLIPASE 
A/ACYLTRANSFERASE (PLA/AT) 
FAMILY 


55 


13.30 


Bela Szabo 
and Mario Lederer 


CALCIUM RELEASE FROM THE 

ENDOPLASMIC RETICULUM 
CONTRIBUTES TO TRIGGERING 
ENDOCANNABINOID PRODUCTION 
IN CEREBELLAR PURKINJE CELLS 


56 


13.45 


Nolan D. Hartley, 
Daniel J. Hermanson, 
Lawrence J. Marnett 
and Sachin Patel 


SUBSTRATE SELECTIVE INHIBITION 
OF COX-2 AS A NOVEL STRATEGY 
FOR IN VIVO ENDOCANNABINOID 
AUGMENTATION 


57 


14.00 


Melissa V. Turman, 
Daniel Hermanson, 
Jeffery J. Prusakiewicz, 

Philip J. Kingsley, 
Andrews S. Felts, Kelsey 
C. Duggan, Sachin Patel 
and Lawrence J. Marnett 


ACETAMINOPHEN AND ITS 
METABOLITES, 4-AMINOPHENOL AND 
AM-404, ARE SUBSTRATE-SELECTIVE 
INHIBITORS OF ENDOCANNABINOID 
OXYGENATION BY 
CYCLOOXYGENASE-2 


58 


14.15 


KwanNok Leung, 
Stephanie Vivieca, Jing 
Sun, Sherrye T. Glaser, 
Dale G. Deutsch 
and Martin Kaczocha 


FLAT IS NOT AN INTRACELLULAR 
ANAND AMIDE TRANSPORTER 


59 


14.30 


Attila Olah, Balazs I. 
Toth, Attila G. Szollosi, 

Lidia Ambrus, 
Christos C. Zouboulis 
and Tamas Biro 


FATTY ACID AMIDE HYDROLASE 
INHIBITORS EXERT COMPLEX 
ANTI-ACNE ACTIONS IN 
HUMAN SEBOCYTES 


60 



14.45 


Julian Romero, Carolyn 
Tanner, Richard Lennertz, 
Amanda Smith, 
Cheryl L. Stucky 
and Cecilia J. Hillard 


T ONFd-TFRM CHANFCIFS TM FATTY ACTD 
AMIDE HYDROLASE KNOCKOUT MICE: 
INVOLVEMENT OF THE TRANSIENT 
RECEPTOR POTENTIAL 
VANILLOID 1 RECEPTOR 


61 


15.00 


Lalita D. Shrestha 
and Cecilia J. Hillard 


REGULATION OF 
MONOACYLGLYCEROL LIPASE 
FUNCTION BY PHOSPHORYLATION 


62 


15.15 


Coffee Break 


15.45 


William T. Berger, 
Brian P. Ralph, Jing Sun, 
Martin Kaczocha, Trent E. 
Balius, Robert C. Rizzo, 
Iwao Ojima 
and Dale G. Deutsch 


VIRTUAL SCREENING FOR INHIBITORS 
OF THE AN AND AMIDE TRANSPORTER 
(FATTY ACID BINDING PROTEINS) 


63 


16.00 


Carmen Vazquez, Marta 
Moreno, Lourdes Ruiz- 
Valdepeiias, Elena Tomas, 
Samuel Ruiz de Martin, 
Rosa Maria Tolon 
and Julian Romero 


FATTY ACID AMIDE HYDROLASE 
DELETION POTENTIATES IN VIVO 
GLIAL ACTIVITY IN RESPONSE TO 
ACUTE BRAIN INJURY 


64 


Oral Session 10. in Memoriam of ester Fride: 
endocannabinoids and development 

Chairs: Sharon AnavlGofferand Mauro Maccarrone 


16.15 


OPENING REMARKS 


16.25 


Mauro Maccarrone, 
Mariangela Pucci, Sara Di 
Siena, Daniele Di 

Giacomo, Valentina 
Pirazzi, Raffaele Geremia 

and Paola Grimaldi 


REGULATION OF THE FAAH GENE 
BY ESTROGEN ENGAGES HISTONE 
DEMETHYLASE LSD1 


65 



16.40 


Tiziana Rubino, Pamela 
Prini, Erica Zamberletti, 
Simona Speziali 
and Daniela Parolaro 


THE ENDOCANNABINOID SYSTEM 

PLAYS A ROLE IN NEURONAL 
REFINEMENT OCCURRING IN THE 
ADOLESCENT PREFRONTAL CORTEX 


66 


16.55 


Chris M. Friemel, 
Rainer Spanagel 
and Miriam Schneider 


ACUTE AND CHRONIC CANNABINOID 
TREATMENT DIFFERENTLY AFFECT 
ETHANOL INTAKE IN PUBERTAL 
AND ADULT RATS 


67 


17.10 


Sangeetha Gajendra, 
Madeleine Oudin, 
Patrick Doherty 
and Giovanna Lalli 


A CANNABINOID-RALA SIGNALLING 
PATHWAY CONTROLLING NEURAL 
PROGENITOR MIGRATION 


68 


17.25 


Sharon Anavi-Goffer, 
Merav Hajby, Dorian 
Solomon, Alex Naftaly, 
Ont Karmmsky, Raphael 
Mechoulam, Iain R. 
Greig, Ruth A. Ross, 
Peter McCaffery 
and Kirsty Shearer 


ALTERATIONS IN CANNABINOID 
SIGNALLING CONTRIBUTE 
TO ADHD-LIKE SYMPTOMS 
AT ADULTHOOD 


69 


17.40-18.40 


ICRS BUSINESS MEETING 


19.00-23.00 


ICRS BANQUET 



DEPARTURE: FRIDAY, JULY 27™ 



POSTER SESSION 1: TOPICS A - D 

DAY 1, MONDAY, JULY 23 rd : 15:45 - 17:45 


TOPIC A NEURODEGENERATION 


Robert B Laprairie, 
Melanie E M Kelly 
and Eileen M Denovan-Wright 


TYPE 1 CANNABINOID RECEPTOR (CBl)-MEDIATED 
INDUCTION OF CB1 EXPRESSION IN CELLULAR MODELS 
OF HUNTINGTON'S DISEASE 


Pl-1 


Hamad Al-Harbi, 
David A Kendall 
and Stephen PH Alexander 


EFFECTS OF CANNABIDIOL AND HU210 ON VIABILITY 
OF SH-SY5Y HUMAN NEUROBLASTOMA CELLS 


Pl-2 


Pazos MR, Mohamed N, 
Martinez-Pinilla E, Ceprian M, 
Lafuente H, Santos M, Romero J, 
Alvarez FJ, Franco R, Hillard C 
and Martinez-Orgado J. 


INVOLVEMENT OF CB2 AND 5HT1A RECEPTORS IN 
CANNABIDIOL-INDUCED NEUROPROTECTION AFTER 
HYPOXIA-ISCHEMIA IN NEWBORN PIGS 


Pl-3 


Ceprian M, Pazos MR, 
Mohammed N, Santos M, 
Mechoulam R 
and Martinez-Orgado J. 


THE CB2 AGONIST HU308 REDUCES BRAIN 
HYPOXIC-ISCHEMIC DAMAGE IN NEWBORN RATS 


Pl-4 


Pazos MR, Mohammed N, 
Ceprian M, Santos M 
and Martinez-Orgado J. 


NEUROPROLIFERATIVE EFFECT OF 
CANNABIDIOL ADMINISTRATION TO NEWBORN 
RATS AFTER HYPOXIA-ISCHEMIA 


Pl-5 


Sonja Kallendrusch, Faramarz 
Dehghani and Marco Koch 


THE GPR55 LIGAND L-01-LYSOPHOSPHATIDYLINOSITOL 
(LPI) EXERTS NEUROPROTECTIVE EFFECTS AFTER 
EXCITOTOXIC LESION IN VITRO 


Pl-6 


Carmen Vazquez, Marta 
Moreno, Lourdes Ruiz- 
Valdepenas, Samuel Ruiz de 
Martin, Elena Tomas, Rosa Maria 
Tolon and Julian Romero 


CANNABIDIOL POTENTIATES IN VIVO MICROGLIAL 
ACTIVITY IN RESPONSE TO ACUTE BRAIN INJURY 


Pl-7 


Balapal S. Basavarajappa, 
Madhu Shivakumar, 
Delphine Psychoyos, 
Shan Xie 
and Shivakumar Subbanna 


AEA/CB1R SIGNALING CONTRIBUTES TO FETAL 
ALCOHOL SPECTRUM DISORDER 


Pl-8 


Iryna A. Khasabova, Matt Tracy, 

Natalya Burlakova, Sergey 
G.Khasabov, Catherine Harding- 
Rose, Donald A. Simone 
and Virginia S. Seybold 


FACILITATION OF ANANDAMIDE SIGNALING REDUCES 
NEUROTOXICITY PRODUCED BY CISPLATIN 


Pl-9 


Marie-Louise Zeissler, C. Oliver 
Hanemann, John P. Zajicek 
and Camille B. Carroll 


THE FAAH INHIBITOR URB597 IS PROTECTIVE 
AGAINST MPP+ IN A CELL CULTURE 
MODEL OF PARKINSON'S DISEASE 


Pl-10 



Alex Straiker, Meggie D Beazley, 
Sherry Shu- Jung Hu, 
Suresh Viswanathan, 

Heather Bradshaw 
and Melanie EM Kelly 


EVIDENCE THAT A FUNCTIONAL GPR18-BASED 
SIGNALING SYSTEM IN THE ANTERIOR MURINE EYE 
MODULATES INTRAOCULAR PRESSURE 


PM1 


John Zajicek 


WHAT DO RESULTS FROM THE CANNABINOID USE IN 
PROGRESSIVE INFLAMMATORY BRAIN DISEASE 
(CUPID) TRIAL TELL US ABOUT THE POTENTIAL 
OF CANNABINOIDS FOR NEUROPROTECTION? 


PM2 


Mauro Maccarrone, Valerio 
Chiurchiu, Maria Teresa 
Cencioni, Elisa Bisicchia, Marco 
De Bardi, Claudio Gasperini, 
Diego Centonze 
and Luca Battistini 


AN AND AMIDE HAS DISTINCT EFFECTS 
ON HUMAN MYELOID AND PLASMACYTOID 
DENDRITIC CELLS IN MULTIPLE SCLEROSIS 


PM3 


TOPIC B. METABOLIC REGULATION / CARDIOVASCULAR 


Paul A.K.E. Gyimah 
and W. -S. Vanessa Ho 


EFFECTS OF HIGH GLUCOSE ON THE 
VASCULAR ACTION OF ANAND AMIDE 
IN YOUNGER AND OLDER RATS 


PM4 


Lucie Geurts, Nathalie M. 
Delzenne and Patrice D. Cani 


CHRONIC ENDOCANNABINOID SYSTEM ACTIVATION 

AND METABOLIC ENDOTOXEMIA DIFFERENTIALLY 
AFFECT THE ONSET OF GLUCOSE INTOLERANCE AND 
INFLAMMATION IN HIGH-FAT DIET-INDUCED 
METABOLIC ALTERATIONS 


P145 


Emmelie Bjorklund, Anders E. 
Blomqvist, Daniele Piomelli, 
Giovanni Bottegoni 
and Christopher J. Fowler 


FUNCTIONAL MEASUREMENT OF FLAT-SENSITIVE 
ANANDAMIDE UPTAKE INTO THREE RAT CELL LINES 


PM6 


Li-Sheng Jiang, Xiao-Jin Huang, 
Ying-Min Chen and Ben He 


ROLE AND MECHANISM OF CANNABINOID CB2 
RECEPTOR ACTIVATION IN REGULATING THE 
EFFEROCYTOSIS FUNCTION OF MACROPHAGE 


PM7 


Tiziana Bisogno, Anu 
Mahadevan, Roberto Coccurello, 
Jae Won Chang, Marco Allara, 
Yugang Chen, Aron Lichtman, 
Benjamin F. Cravatt, Anna Moles 
and Vincenzo Di Marzo 


DESIGN, SYNTHESIS AND PHARMACOLOGICAL 
ACTIVITY OF O-7460, A NOVEL FLUOROPHOSPHONATE 
INHIBITOR OF THE BIOSYNTHESIS 
OF 2-ARACHIDONOYL-GLYCEROL 


PM8 


Edgar Soria-Gomez, 
Luigi Bellocchio, Mounir 
Bendahmane, Leire Reguero, 
Astrid Cannich, Elodie Richard, 
Pedro Grandes, Hirac Gurden 
and Giovanni Marsicano 


CANNABINOID TYPE-1 (CBl)-DEPENDENT REGULATION 
OF FOOD INTAKE IN THE OLFACTORY BULB 


PM9 



A J Wheal, S E O'Sullivan 
and M D Randall 


ACUTE VASCULAR EFFECTS OF ENDOCANNABINOIDS 
IN THORACIC AORTAE FROM ZUCKER DIABETIC RATS 


Pl-20 


Barbara Malinowska, Emilia 
Grz^da and Eberhard Schlicker 


INVOLVEMENT OF THE HYPOTHALAMIC 

PARAVENTRICULAR NUCLEUS IN THE 
PRESSOR EFFECT OF THE CANNABINOID 
RECEPTOR AGONIST CP55940 


Pl-21 


Cristoforo Silvestri, Andrea 
Martella, Fabiana Piscitelli, 
Neil Poloso, David Woodward 
and Vincenzo Di Marzo 


THE PROSTAMIDE ANALOGUE BIMATOPROST 
INHIBITS ADIPOGENESIS 


Pl-22 


William H Hind 
and Saoirse E O'Sullivan 


CANNABIDIOL PROTECTS THE BLOOD-BRAIN BARRIER 
AGAINST INCREASED PERMEABILITY FOLLOWING 
OXYGEN -GLUCOSE DEPRIVATION 


Pl-23 


C P Stanley 
and Saoirse E O'Sullivan 


2-AG RESPONSES ARE BLUNTED IN PATIENTS WITH 
CARDIOVASCULAR DISEASE AND CARDIOVASCULAR 
DISEASE RISK FACTORS 


PI -24 


C P Stanley 
and Saoirse E O'Sullivan 


CANNABIDIOL INDUCED VASORELAXATION 
OF HUMAN MESENTERIC ARTERIES IS MEDIATED 
BY THE ENDOTHELIUM, CB1 AND TRPV1 


Pl-25 


Lysanne Campeau, Claudius 
Fullhase, Allyn Howlett 
and Karl-Erik Andersson 


CYSTOMETRIC EFFECTS OF SPINAL CANNABINOID 
RECEPTOR ACTIVATION IN NORMAL RATS 


Pl-26 


Lysanne Campeau, Claudius 
Fullhase, Allyn Howlett 
and Karl-Erik Andersson 


ROLE OF TRPV1 RECEPTORS IN THE SPINAL 
EFFECTS OF N-ACYL-ETHANOLAMINE ON 
THE MICTURITION IN THE NORMAL RAT 


Pl-27 


Raj Kamal Srivastava 
and Beat Lutz 


DYSREGULATION OF HYPOTHALAMIC-PITUITARY- 
ADRENAL AXIS IN MICE LACKING CB1 RECEPTOR IN 
ADRENERGIC AND NORADRENERGIC NEURONS 


Pl-28 


Paolo Lazari 
and Andrea Mastinu 


NOVEL SELECTIVE CB1 ANTAGONIST 
AGENT WITH ANTI-OBESITY ACTIVITY 


Pl-29 



Topic C. psychiatric diseases / learning & memory 


Sabrina F. Lisboa, 
Felipe V. Gomes 
and Francisco S. Guimaraes 


CANNABIDIOL ATTENUATES ISOLATION- 
INDUCED AGGRESSION IN MICE BY 
ACTIVATION OF 5-HT1A RECEPTORS 


Pl-30 


Fabricio A. Moreira, Luciano R. 

Vilela, Daniel C. Medeiros, 
Gustavo H. Rezende, Antonio C. 
Oliveira and Marcio F. Moraes 


EFFECTS OF CANNABINOIDS AND ENDOCANNABINOID- 
HYDROLYSIS INHIBITION ON PENTYLENETETRAZOLE- 
INDUCED SEIZURES AND 
ELECTROENCEPHALOGRAPHIC ACTIVITY 


Pl-31 


Martin A. Sticht 
and Linda A. Parker 


THE ROLE OF INTRA- VISCERAL INSULAR CORTEX 2AG 
IN CONDITIONED NAUSEA-LIKE BEHAVIOR IN RATS 


Pl-32 


Anja A. Goepfrich , Matthias 
Klugmann, Thomas Enkel 
and Miriam Schneider 


ADULT RATS OVEREXPRESSING THE CB1 RECEPTOR IN 
THE MPFC DISPLAY ALTERED EMOTIONAL BEHAVIOR 
AND PMPAIRED EXTINCTION OF FEAR MEMORY 


Pl-33 


Ryan J. McLaughlin, 
Matthew N. Hill, 
Tiffany Lee, Jay Schulkin, 
Cecilia J. Hillard 
and Bruce S. McEwen 


CRH MEDIATES THE EFFECTS OF GLUCOCORTICOIDS ON 
ENDOCANNABINOID SIGNALING IN THE AMYGDALA 


Pl-34 


Daniela Hauer, Hannah Gola, 
Patrizia Campolongo, 
Iris-Tatjana Kolassa 
and Gustav Schelling 


PLASMA LEVELS OF ENDOCANNABINOIDS 
AND RELATED PRIMARY FATTY ACID 
AMIDES ARE INCREASED IN PATIENTS 

WITH POST-TRAUMATIC STRESS DISORDER 


Pl-35 


Tiffany T.-Y. Lee, Matthew N. 
Hill, Sarah B. Filipski 
and Bruce S. McEwen 


MORPHOLOGICAL AND BEHAVIOURAL EVIDENCE 
FOR IMPAIRED PREFRONTAL CORTICAL FUNCTION 
IN FEMALE CB1 RECEPTOR DEFICIENT MICE 


Pl-36 


Vincenzo Micale, Fabricio A. 
Pamplona, Alexandra Sulcova, 
Filippo Drago 
and Carsten T. Wotjak 


THE MODULATION OF THE ENDOCANNABINOID 
SIGNALING MEDIATES THE EXTINCTION 
OF AVOIDANCE BEHAVIOR BY CONTROLLING 
SAFETY LEARNING 


Pl-37 


Irena Smaga, Aneta 
Piwowarczyk, Beata Bystrowska 
and Malgorzata Filip 


CriAJNGhblJN itih LEVEL Ur EJN DUC, AN IN AdIJN UlDb 

AND ENDOCANNABINOID-LIKE MOLECULES 
AFTER ACUTE AND REPEATED ADMINISTRATION 
OF IMIPRAMINE AND N- ACETYLCYSTEINE IN 
DIFFERENT RAT BRAIN STRUCTURES 


Pl-38 


Hila Abush and Irit Akirav 


CANNABINOIDS AMELIORATE IMPAIRMENTS 
INDUCED BY CHRONIC STRESS TO SYNAPTIC 
PLASTICITY AND SHORT-TERM MEMORY 


Pl-39 



Amir Segev and Irit Akirav 


CANNABINOID AND GLUCOCORTICOID RECEPTORS 
IN THE AMYGDALA MODULATE THE STRESS-INDUCED 
IMPAIRMENT OF LTP IN THE HIPPOCAMPAL- 
ACCUMBENS PATHWAY 


PI -40 


Teniel S. Ramikie 

CllLU i^aV-l L±l L J- CI LCI 


ENDOCANNABINOID-MEDIATED SYNAPTIC 
DEPRESSION IN THE CENTRAL AMYGDALA: 
CHOLINERGIC-CANNABINOID INTERACTIONS 


Pl-41 


Felicha T. Candelaria-Cook 
and Derek A. Hamilton 


CHRONIC WIN 55,212-2 EXPOSURE AND DENTATE 
DENDRITIC MORPHOLOGY IN ADULT RATS 


PI -42 


Robert E. Hampson, 
Cheryl Ann Sexton, 
John Sesay, 
Anushka Goonawardena 
and Sam A. Deadwyler 


CANNABINOIDS ALTER REVERSAL 
OF BEHAVIORAL CONTINGENCY 
BY SUPPRESSING MEMORY-RELATED ENCODING 


PI -43 


Yosef Same, Miriam Fishbein, 
Sahar Gov, Ora Keren 
and Mikhal Garni 


EXTREMELY LOW DOSES OF 
TETRAHYDROCANNABINOL PROTECT FROM 
COGNITIVE DEFICITS AND INDUCE LONG-LASTING 
BIOCHEMICAL CHANGES IN THE MOUSE BRAIN 


PI -44 


Roberto Colangeli, Ines Santolini, 
Silvana Gaetani, Ferdinando 
Nicoletti, Richard Ngomba 
and Vincenzo Cuomo 


ALTERATIONS OF CB1 mRNA EXPRESSION 

IN STARGAZER MUTANT MICE AND IN 
PENTYLENETETRAZOLE-INDUCED SPIKE 
AND WAVE DISCHARGES IN RATS 


Pl-45 


Alex Naftaly, Shimon Rabichev, 
Orit Karminsky, Jiirg Gertsch, 
Ken Mackie Tibor Harkany, 
Ruth A. Ross, Ester Fride 
and Sharon Anavi-Goffer 


REDUCED EXPLORATION BEHAVIOUR BY NMDA 
ANTAGONIST IS REVERSED BY HU-308 


PI -46 


Fabricio A. Moreira, Luciano R. 

Vilela, Daniel C. Medeiros, 
Gustavo H. Rezende, Antonio C. 
Oliveira and Marcio F. Moraes 


EFFECTS OF CANNABINOIDS AND ENDOCANNABINOID- 
HYDROLYSIS INHIBITION ON PENTYLENETETRAZOLE- 
INDUCED SEIZURES AND 
ELECTROENCEPHALOGRAPHIC ACTIVITY 


Pl-47 


Floor Remmers, Sabine Ruehle, 
Hector Romo-Parra, Federico 
Massa, Melanie Wickert, Nadine 
Kaiser, Giovanni Marsicano, 
Hans-Christian Pape 
and Beat Lutz 


ENDOCANNABINOID SIGNALLING AND 
FEAR EXTINCTION IN MOUSE LINES FOR 
GLUTAMATERGIC AND GABAERGIC-SPECIFIC 
RESCUE FROM CB1 RECEPTOR DEFICIENCY 


PI -48 


Vanessa Enk, Martin Haring, 
Floor Remmers, Sabine Riihle 
and Beat Lutz 


EXPLORATORY BEHAVIOR AND RESPONSE TO THC IN 
MOUSE LINES FOR GLUTAMATERGIC AND GABAERGIC- 
SPECIFIC RESCUE FROM CB1 RECEPTOR DEFICIENCY 


PI -49 



Topic D. cannabis 


Donald P. Land 
and Kymron B. deCesare 


CANNABIS IN (NORTHERN) CALIFORNIA, 
2011-2012: STATISTICS AND TRENDS FROM 
THOUSANDS OF INDIVIDUAL SAMPLES TESTED 
FOR 15 CANNABINOIDS AND 8 TERPENOIDS 


Pl-50 


Adam Ogden, Andrew Higham 
and Karen Wright 


IMPORTANCE OF REFERENCE GENES IN 
VALIDATING THE EFFECTS OF CANNABIDIOL 
ON FIBROTIC PROCESSES 


Pl-51 


Zlatko Mehmedic, Mohamed M. 

Radwan, Suman Chandra, 
Mudasir Tantry, Afeef S. Husni, 
Stephen Cutler, Ikhlas A. Khan 
and Mahmoud A. hlsohly 


VOLATILE OIL FROM HIGH POTENCY 
CANNABIS SATIVA WITH IN VITRO BINDING 
AFFINITY FOR HUMAN CANNABINOID RECEPTORS 


Pl-52 


Patrik Roser, Silke Lissek, Martin 
Tegenthoff, Volkmar Nicolas, 
Georg Juckel and Martin Briine 


ALTERATIONS OF THEORY OF MIND NETWORK 
ACTIVATION IN CHRONIC CANNABIS USERS 


Pl-53 


Kristen Courtney 


CANNABIS USE IN PREGNANCY AND BREASTFEEDING 


Pl-54 




POSTER SESSION 2: TOPICS E - G 

DAY 2, TUESDAY, JULY 24 th : 16:00 - 18:00 


Topic E. receptor Signaling 


M. Genedy, 
N. Hoenig, M. Youseffi 
and M.C.T. Denyer 


EFFECT OF CANNABINOIDS (WIN55,212-2) 
IN ACCELERATION OF WOUND HEALING 
IN BONE CELL MONOLAYER 


P2-1 


M. Genedy, M. Youseffi 
and M.C.T. Denyer 


EFFECT OF CB2 SELECTIVE AGONIST ON 
WOUNDED BONE CELL MONOLAYERS 


P2-2 


A. Abdeldayem, M. Yousseffi 
and M.C.T. Denyer 


THE EFFECT OF DIFFERENT CONCENTRATIONS OF 
CANNABINOID (WIN 55,212-2) ON WOUND HEALING 
OF CHONDROCYTE MONOLAYER 


P2-3 



A. Abdeldayem, M. Yousseffi 
and M.C.T. Denyer 


THE EFFECT OF DIFFERENT CONCENTRATIONS 
OF THE SYNTHETIC CANNABINOIDS WIN 55,212-2, 
URB602 AND HU-308 ON WOUND HEALING OF 
CHONDROCYTE MONOLAYER 


P2-4 


Philip W. Brownjohn 
and John C. Ashton 


PROTEOMIC IDENTIFICATION OF THE RAT 
CANNABINOID CB2 RECEPTOR USING MASS 
SPECTROMETRY AND IMMUNOBLOTTING 


P2-5 


Dina Navia-Paldanius, 
Niina Aaltonen, Marko 
Lehtonen, Ulrike Taschler, 
Franz P. Radner, 
Robert Zimmermann 
and Jarmo T. Laitinen 


BRAIN REGIONAL DESENSITIZATION OF CANNABINOID 

CB1 RECEPTOR SIGNALING IN MICE WITH GLOBAL 
GENETIC KNOCKOUT OF MONOACYLGLYCEROL LIPASE 


P2-6 


Pekkala S, Wiklund P, Hulmi JJ, 

Marjomaki V, Alen M, 
Pollanen E, Fachada V, Mero AA 
and Cheng S 


CANNABINOID RECEPTOR 1 REGULATES 
PROTEIN SYNTHESIS AND TRANSLATION 
IN HUMAN SKELETAL MUSCLE 


P2-7 


Jahan P. Marcu, Steven N. Popoff 
and Mary E. Abood 


CB1 AND CB2 ANTAGONIST 
SIGNALING IN OSTEOBLASTS 


P2-8 


Gemma L. Baillie, Roger G. 
Pertwee and Ruth A. Ross 


SIGNALLING TRAFFICKING AT THE 
CANNABINOID CB1 RECEPTOR BY THE CB1 
ALLOSTERIC MODULATOR, ORG 27569 


P2-9 


William A. Devane, David L. 
Stevens, David P. Finn, Ntsang 

M. Nebane, Zhao-Hui Song, 
David Peters, Duncan Crawford, 
J. Michael Walker, Benjamin 
Applegate, John M. Kennish, 
Michael P. Cassidy, Dana E. 
Selley, Anne Zimmer, Andreas 
Zimmer and William L. Dewey 


LEELAMINE, A NOVEL DITERPENE, EXHIBITS 
CANNABIMIMETIC EFFECTS IN CB1 RECEPTOR 
KNOCKOUT MICE 


P2-10 


Richard S. Priestley, 
Stephen P.H. Alexander 
and David A. Kendall 


EARLY AND LATE PHASE ERK RESPONSES REVEAL 
A NOVEL FUNCTIONALLY SELECTIVE AGONIST PROFILE 
AT CANNABINOID TYPE 1 RECEPTORS 


P2-11 


Chris S. Breivogel 
and Manan Vaghela 


BETA-ARRESTIN1 MEDIATION OF 
THE EFFECTS OF CANNABINOID LIGANDS 


P2-12 


Alex Straiker, Laura Pardon, 
Lisa Walter, Nephi Stella 
and Suresh Viswanathan 


EVIDENCE FOR A FUNCTIONAL ROLE 
OF CB1 CANNABINOID RECEPTORS IN THE 
MAMMALIAN CONE PATHWAY 


P2-13 


Linda Console-Bram, Eugen 
Brailoiu, Cristina Brailoiu 
and Mary E. Abood 


CALCIUM MOBILIZATION AND MAPK 
ACTIVITY VIA GPR18 


P2-14 



Jagjeet Singh, Diane Lynch, 
Zhao-Hui Song 
and Patricia H. Reggio 


THE IMPORTANCE OF THE CB2 HOMODIMER TO THE 
CB2 CATALYZED ACTIVATION OF Gi PROTEIN 


P2-15 


Lysann Palkowitsch, 
Julia Benkert, Sebastian Rading, 
Barbara Mopps 
and Meliha Karsak 


TCTEX1 - 

A PUTATIVE CB2 RECEPTOR REGULATING PROTEIN 


P2-16 


Natalia Murataeva, Ken Mackie 
and Alex Straiker 


THE CB2-PREFERRING AGONIST JWH015 ALSO 
POTENTLY AND EFFICACIOUSLY ACTIVATES 

r^RI TM A T TT A PTTf T^TTPPOf^ A AA P A T MPT TPOMQ 
LDl UN /\U 1/\1 IIV^. rill 1 LJ^/\1V11 /\L INI EUIvL-'inD 


P2-17 


Jennifer L. Hollis 
and Heather B. Bradshaw 


PUTATIVE CANNABINOID RECEPTOR GPR18 IS 
PRODUCED IN RAW 264.7 MACROPHAGE CELLS 


P2-18 


Kristin Hines 
and Heather Bradshaw 


N-ARACHIDONOYL GLYCINE ACTIVATION OF p44/42 
MAPK IN HUMAN ENDOMETRIAL CARCINOMA CELLS 


P2-19 


Somnath Mukhopadhyay, 
Genevieve Laroche, 
Vladimir Poltoratsky 
and David Siderovski 


TUNING CANNABINOID RECEPTOR 
SIGNALING BY RGS12 (REGULATORS OF 
G-PROTEIN SIGNALING) PROTEIN 


P2-20 


Topic F. Drug Addiction 


A. Llorente-Berzal, 
E. Puighermanal, A. Burokas, 

A. Ozaita, R. Maldonado, 
E.M. Marco and M.P. Viveros 


SEX DEPENDENT BEHAVIORAL AND MOLECULAR 
EFFECTS OF THC AND MDMA IN AN ANIMAL MODEL 
OF ADOLESCENT DRUG CONSUMPTION 


P2-21 


Lile JA, Kelly TH, Stinchcomb 
AL, Charnigo RJ, Forester EB, 
Hudson DA, Neltner MJ 
and Hays LR 


PHARMACOKINETIC AND PHARMACODYNAMIC 
EFFECTS OF SUPRA-THERAPEUTIC A 9 -THC 
DOSES IN CANNABIS USERS 


P2-22 


Amir Englund, Paul Morrison, 
Judith Nottage, Dominic Hague, 
Fergus Kane, Stefania 
Bonaccorso, James Stone, Avi 
Reichenberg, Rudolf Brenneisen, 
David Holt, Amanda Fielding, 
Dominic ffytche, Robin Murray 
and Shitij Kapur 


CANNABIDIOL INHIBITS THC-ELICITED PSYCHOSIS 
AND MEMORY IMPAIRMENTS IN HUMANS 


P2-23 


Salvatore Lecca, Antonio 
Luchicchi, Marta De Felice 
and Marco Pistis 


MATERNAL IMMUNE ACTIVATION DISRUPTS THE 
FUNCTIONALITY OF MESOLIMBIC DOPAMINE 
NEURONS: INVOLVEMENT OF CANNABINOIDS 


P2-24 



Beata Bystrowska, Karolina 
Wydra, Agata Suder, Irena 
Smaga and Malgorzata Filip 


CHANGES IN CONCENTRATION OF 
ENDOCANNABINOIDS AND N-ACYL ETHANOLAMIDES 
IN BRAIN STRUCTURES OF RATS UNDERWENT COCAINE 
SELF-ADMINISTRATION AND ITS WITHDRAWAL 


P2-25 


Iain S. McGregor, Alex Wong, 
Kong M. Li, 
Jonathon C. Arnold 
and Wendy Swift 


CANNABIS POTENCY IN NEW SOUTH 
WALES AUSTRALIA: AN ANALYSIS OF POLICE 
SEIZED STREET SAMPLES 


P2-26 


Thomas Gamage, Divya Ramesh, 
Rehab Abdullah, 
Micah J. Niphakis, Ben Cravatt 
and Aron Lichtman 


DUAL FAAH/MAGL INHIBITION ATTENUATES 
SOMATIC SIGNS OF SPONTANEOUS MORPHINE 
WITHDRAWAL IN ICR MICE 


P2-27 


Matthew F. Lazenka, 
Eric J. Nestler, Dana E. Selley 
and Laura J. Sim-Selley 


ROLE OF AFOSB IN CB1R DESENSITIZATION IN THE 
BASAL GANGLIA 


P2-28 


Sofia B. Gustafsson 
and Stig O. P. Jacobsson 


EFFECTS OF CANNABINOIDS ON THE DEVELOPMENT 
OF CHICK EMBRYOS IN OVO 


P2-29 


Fabiana Piscitelli, Aron 
Lichtman, Laura Sim-Selley, 
Robert Hamm, Tiziana Bisogno, 
Vincenzo Di Marzo 
and Raphael Mechoulam 


TARGETED LIPIDOMICS PROFILING OF INJURED 
RAT BRAIN: POSSIBLE IMPLICATIONS FOR 
NICOTINE DEPENDENCE 


P2-30 


Emmanuel S. Onaivi, 
Hiroki Ishiguro, Alvaro Llorente- 
Berzal, Maria-P Viveros 
and George R. Uhl 


CANNABINOID RECEPTORS: GENE STRUCTURES, SNPS, 
CNVS, CPG ISLANDS MICRORNA REGULATION AND 
VARIATION IN NEUROPSYCHIATRY DISORDERS 


P2-31 


Bela Szabo, Volker Auwarter, 
Mario Lederer, Stefan Kneisel 
and Maren Hermanns-Clausen 


ACUTE INTOXICATIONS FOLLOWING 
CONSUMPTION OF HERBAL PRODUCTS 
CONTAINING SYNTHETIC CANNABINOIDS 


P2-32 


TOPIC G. CANCER / IMMUNOLOGY 


Torsten Lowin, Angelika Graber, 
Elena Neumann 
and Rainer H. Straub 


ANAND AMIDE ATTENUATES THE 
INFLAMMATORY PHENOTYPE OF RHEUMATOID 

ARTHRITIS SYNOVIAL FIBROBLASTS BY 
ACTIVATING MULTIPLE RECEPTOR PATHWAYS 


P2-33 


Torsten Lowin, Wentao Zhu, 
Katja Dettmer, Elena Neumann 
and Rainer H. Straub 


CORTISOL-INDUCED ADHESION OF 
SYNOVIAL FIBROBLASTS IS MEDIATED 
BY THE ENDOCANNABINOID SYSTEM 


P2-34 



Wook Kim, Qizong Lao, 
Yu-Kyong Shin, Olga D. Carlson, 
Eun Kyung Lee, Myriam 
Gorospe, Rohit N. Kulkarni 
and Josephine M. Egan 


CANNABINOIDS INDUCE PANCREATIC 
BETA-CELL DEATH BY DIRECTLY INHIBITING 
INSULIN RECEPTOR ACTIVATION 


P2-35 


Daniel Kerr, Brendan Harhen, 
David P. Finn 
and Michelle Roche 


PHARMACOLOGICAL INHIBITION OF 
MONOACYLGLYCEROL LIPASE ATTENUATES 
LPS-INDUCED INCREASES IN CYTOKINE EXPRESSION 
IN THE RAT FRONTAL CORTEX AND PLASMA: 


P2-36 


Daniel Roskowski, 
Douglas McHugh, Siyun Xie 
and Heather B. Bradshaw 


N-ARACHIDONOYL GLYCINE REGULATES THE 
PHENOTYPIC MORPHOLOGY OF BV-2 MICROGLIA 


P2-37 


Evan Jameyfield, Siham 
Raboune, Douglas McHugh 
anu nearner d. Drausnaw 


NOVEL ENDOGENOUS N-ACYL AMIDES INDUCE 
CALCIUM MOBILIZATION IN BV-2 MICROGLIA 


P2-38 


Douglas McHugh, Jeremy Page 
and Heather B. Bradshaw 


N-ARACHIDONOYL GLYCINE AND A 9 -THC REGULATE 
THE CYTOKINE PRODUCTION OF BV-2 MICROGLIA 


P2-39 


Seok-Woo Park 
and Myung-Whun Sung 


CANNABINOID RECEPTOR-INDEPENDENT 
ANTIPROLIFERATIVE EFFECT OF DOCOSAHEXAENOYL 
ETHAN OLAMIDE IN HEAD AND NECK SQUAMOUS 
CELL CARCINOMA CELLS 


P2-40 


Benjamin Gennequin, 
David-Marian Otte, Katrin 
Zimmermann, Anne Zimmer 
and Andreas Zimmer 


FUNCTIONAL ANALYSIS OF THE HUMAN CB2 
RECEPTOR VARIANTS 


P2-41 


Luciano De Petrocellis, 
Alessia Ligresti, Aniello Schiano 
Moriello, Roberta Verde, 
Pierangelo Orlando, 
Colin G. Stott 
and Vincenzo Di Marzo 


CANNABINOIDS IN PROSTATE CANCER: AN UPDATE 


P2-42 


Svenja S. Ternes, Judith Alferink 
and Andreas Zimmer 


REGULATION OF INFLAMMATORY PROCESSES 
BY THE ENDOCANNABINOID SYSTEM 


P2-43 


Christeene Haj, 
Percy F. Sumariwalla, Natalya 
Kogan, Zhanna Yektin, 
Marc Feldmann, Raphael 
Mechoulam and Ruth Gallily 


NOVEL CANNABIDIOL DERIVATIVES AND 
THEIR USE AS ANTI-INFLAMMATORY AGENTS 


P2-44 


Toguri, J.T., Szczesniak, A.M., 
Zhou, J., Lehmann, C. 
and Kelly, M.E.M 


CANNABINOID MODULATION OF LEUKOCYTE- 
ENDOTHELIAL INTERACTIONS IN AN ENDOTOXIN- 
INDUCED UVEITIS MODEL 


P2-45 



Anna-Maria Szczesniak 
and Melanie E.M. Kelly 


THE ROLE OF CANNABINOID RECEPTOR 2 IN THE 
EXPERIMENTAL AUTOIMMUNE UVEORETINITIS 


P2-46 


Neta Rimmerman, Ana Juknat, 
Ewa Kozela, Ziv Porat, Danya 
Ben-Hail, Varda Shoshan- 
Barmatz and Zvi Vogel 


CANNABIDIOL AFFECTS MITOCHONDRIAL 
TARGETS IN BV-2 MICROGLIAL CELLS 


P2-47 


Jocelijn Meijerink, Mieke Poland, 
Michiel Balvers, Zheng Wang, 
Jvalini Dwarkasing 
and Renger F. Witkamp 


FISHING FOR CANNABINOIDS FROM FISH; IMMUNE- 
MODULATORY MECHANISMS OF AMIDES DERIVED 
FROM N-3 FATTY ACIDS 


P2-48 


Tara Macpherson, John 
Westwick and Karen Wright 


CANNABIDIOL AFFECTS CELLULAR 
BIOENERGETICS IN COLON CANCER 


P2-49 


Amy G. Eubanks, Cameron A. 
Tull, Amber E. Prescott, John R. 
Sims, Emily R. Coffman, Whitley 

\A rlnnnp inl tti on W cj^ptt' 
1VJ-. i i.\J \-> \-> Cy \ \j ill i tv . iviaooCy; 

Nolan J. West, Vikki K. Bennett, 
Cara L. McKinney, Jessica R. 

Winston, Larry J. Suva, Robert J. 
Griffin and Lori L. Hensley 


ANTT-TTTMOR FFFFCTS OF ATT IT FMTC ACTD ON 
THE EWING'S SARCOMA FAMILY OF TUMORS 


P2-50 


A.M. Wasik, S. Almestrand, 
F. Zong, P. Andersson, E. Kimby, 
B. Christensson and B. Sander 


MAPPING OF THE ENDOCANNABINOID SYSTEM 
IN MANTLE CELL LYMPHOMA 


P2-51 


Mohd W. Nasser, Zahida Qamri, 
Konstantin Shilo 
and Ramesh K. Ganju 


CANNABINOID RECEPTOR CB2 CROSSTALK WITH 
CHEMOKINE RECEPTOR CXCR4 TO MODULATE BREAST 
CANCER GROWTH AND METASTASIS 


P2-52 


Somnath Mukhopadhyay, 
Shalini Jha and Victoria Jones 


CB2 RECEPTOR-MEDIATED REGULATION OF I2PP2A 
(INHIBITOR 2 OF PROTEIN PHOSPHATASE 2A): A NEW 
TARGET FOR PROSTATE CANCER TREATMENT 


P2-53 


Benjamin S. Harvey 
and Scott D. Smid 


EFFECTS OF PRO-INFLAMMATORY CYTOKINES 
AND CANNABINOIDS ON INTESTINAL 
EPITHELIAL PERMEABILITY 


P2-54 


June Penman, Alana J. Burns 
and Andrew J. Irving 


L-a-LYSOPHOSPHATIDYLINOSITOL AND AM251 
PROMOTE CYTOSKELETAL REORGANISATION IN 
CANCER CELL LINES THAT EXPRESS GPR55 


P2-55 



POSTER SESSION 3: TOPICS H - J 

DAY 3, WEDNESDAY, JULY 25 th : 10:45 - 12:45 


Topic h. Ligand Development 


Daniel J. Hermanson, 
Nolan D. Hartley, Sachin Patel 
and Lawrence J. Marnett 


DEVELOPMENT OF LM-4131, A SUBSTRATE-SELECTIVE 
INHIBITOR OF CYCLOOXYGENASE-2 


P3-1 


Pritesh Kumar, Akhilesh Kumar 
and Zhao-Hui Song 


STRUCTURE-ACTIVITY RELATIONSHIPS OF LIGANDS 
FOR GPR119 - A GPCR THAT IS RELATED TO 
CANNABINOID RECEPTORS 


P3-2 


Jayendra Z. Patel, Teija Parkkari 
and Tapio Nevalainen 


3,4-DISUBSTITUTED THIADIAZOLES AS 
FAAH AND/OR MGL INHIBITORS 


P3-3 


Andrea Chicca, Janine Marazzi, 
Simon Nicolussi 
and Jiirg Gertsch 


EVIDENCE FOR A BIDIRECTIONAL ENDOCANNABINOID 
TRANSPORT ACROSS CELL MEMBRANES AND 
IDENTIFICATION OF SELECTIVE INHIBITORS 


P3-4 


Roger Slavik, Daniel Bieri, 
Konstantin Drandarov, Adrienne 
Miiller, Stefanie Kramer, Roger 
Schibli, Simon M. Ametamey 
and Linjing Mu 


SYNTHESIS AND EVALUATION OF NOVEL 
CANNABINOID TYPE 2 RECEPTOR TRACERS 
FOR PET IMAGING 


P3-5 


Sari Yrjola, Tuomo Kalliokoski, 
Teija Parkkari, Tuomo Laitinen, 
Antti Poso and Tapio Nevalainen 


2,4,6-TRISUBSTITUTED 1,3,5-TRIAZINES 
AS SELECTIVE CB2 AGONISTS 


P3-6 


Sara Del Carlo, Giuseppe 
Saccomanni, Clementina 
Manera, Giancarlo Pascali, 
Francesca Castelli, Alessia 
Ligresti, Vincenzo Di Marzo, 
Marco Macchia 
and Piero A. Salvadori 


[18F]-LABELED HETEROCYCLIC DERIVATIVES 
FOR PET IMAGING OF CANNABINOID CB2 RECEPTOR 


P3-7 


Barbara Bosier, 
Giulio G. Muccioli, Eric Stern 
and Didier M. Lambert 


4-OXO-l,4-DIHYDROQUINOLINE-3-CARBOXAMIDE 
DERIVATIVES AS FUNCTIONAL SELECTIVE LIGANDS AT 
THE CB2 CANNABINOID RECEPTOR 


P3-8 


Reem Smoum, Saja Baraghithy, 

Aviva Breuer, Malka Attar- 
Namdar, Raphael Mechoulam 
and Itai Bab 


NOVEL CB2 AGONIST HU-433 MODULATES SKELETAL 
REMODELING AND BONE MASS 


P3-9 



Cristina Fernandez-Fernandez, 

Laura Hernandez-Folgado, 
Nadine Jagerovic, Maria Gomez- 
Canas, Maria Gomez-Ruiz, Javier 

Fernandez-Ruiz and Pilar Goya 


SYNTHESIS AND EVALUATION OF NOVEL 
CB2 CANNABINOID LIGANDS 


P3-10 


Jiirgen Fingerle, Uwe Grether, 
Atsushi Kimbara, Matthias 
Nettekoven, Mark Rogers-Evans, 
Stephan Rover, Tanja Schulz- 
Gasch, Christoph Ullmer 
and Franz Schuler 


INITIAL HTS HIT OPTIMIZATION: NOVEL, HIGHLY 
POTENT AND SELECTIVE CB2 AGONISTS 


P3-11 


Valentina Lucchesi, Haleli Sharir, 
Giuseppe Saccomanni, Alessia 
Ligresti, Vincenzo Di Marzo, 
Marco Macchia, Mary E. Abood 
and Clementina Manera 


INVESTIGATION ON l,8-NAPHTHYRIDIN-2(lH)-ON-3- 
CARBOXAMIDES A CLASS OF POTENT CB2 SELECTIVE 
CANNABINOID RECEPTOR LIGANDS: SYNTHESIS, 
STRUCTURE- ACTIVITY RELATIONSHIPS AND 
FUNCTIONAL ACTIVITY 


P3-12 


Herbert H. Seltzman, 
Rangan Maitra, Patricia Reggio, 
Daniel Wesley, Joseph Tarn 
and George Kunos 


IN VIVO METABOLIC EFFECTS OF PIMSR, 
A CANNABINOID CB1 RECEPTOR 
NEUTRAL ANTAGONIST 


P3-13 


Rangan Maitra, Alan Fulp, 
Katherine Bortoff, Herbert 
Seltzman, Yanan Zhang, 
Timothy Fennell, James Mathews 

Jinn RnnTiPV Snvnpr 


TOWARDS RATIONAL DEVELOPMENT 
OF PERIPHERALLY SELECTIVE ANTAGONISTS 
OF CANNABINOID RECEPTOR 1 


P3-14 


Lirong Wang, Junmei Wang, 
Zhaojun Xie, Chao Ma, 
Kyaw Myint and Xiang-Qun Xie 


CLOUD COMPUTING WEBSERVER 
FOR CANNABINOID RESEARCH 


P3-15 


James D Wakefield, Kristie A 
Sykes, Nisha Perez, Stacy D 
Arnett, Vasu Sethuraman, 
Christopher M Graul, James P 
Pearson, G Todd Milne, Albert 
Profy, Robert W Busby 
and Kamlesh P Vyas 


PHARMACOKINETICS AND PHARMACODYNAMICS OF 
A POTENT, SELECTIVE AND ORALLY BIO AVAILABLE 
FAAH INHIBITOR, MM-433593 IN SPRAGUE-DAWLEY 
RATS, CYNOMOLGUS MONKEYS AND HUMAN 


P3-16 


Ming-Shiu Hung, Kak-Shan Shia, 
Teng-Kang Yeh, Jen-Shin Song, 
Chun-Ping Chang, Yinchiu Lin, 
Pei-Chuan Chen, Wen-Chy 
Hsiao and Yu-Sheng Chao 


A NOVEL PERIPHERAL CB1 ANTAGONIST 
REDUCES FOOD INTAKE AND EXHIBITS EFFICACY IN 
IMPROVING ADIPOSITY AND INSULIN RESISTANCE 


P3-17 


Paolo Lazari, Gabriele 
Murineddu, Ilaria Manca, 
Giovanni Loriga 
and Gerard Aime Pinna 


MYRTANIL SUBSTITUENT IN 3 POSITION OF PIRAZOLE 
RING DETERMINES CB1 AGONISM OF NOVEL 4,5- 
DIHYDROBENZO-OXA-CYCLOHEPTAPYRAZOLE 
CANNABINOIDS 


P3-18 


Mario van der Stelt 


DISCOVERY AND OPTIMIZATION OF l-(4-(PYRIDIN-2- 
YL)BENZYL) IMIDAZOLIDINE-2,4-DIONE DERIVATIVES 
AS A NOVEL CLASS OF SELECTIVE CANNABINOID 
CB2 RECEPTOR AGONISTS 


P3-19 



TOPIC I. ENDOCANNABINOIDS & ENZYMES 


Tatsuya Tai, Kazuhito Tsuboi, 
Toru Uyama, Kim Masuda, 
Benjamin F. Cravatt, Hitoshi 
Houchi and Natsuo Ueda 


STIMULATORY EFFECTS OF PHOSPHOLIPIDS AND 
DIHYDROLIPOIC ACID ON N-ACYLETHANOLAMINE- 
HYDROLYZING ACID AMIDASE (NAAA) 


P3-20 


Jayendra Z. Patel, Teija Parkkari, 
Susanna M. Saario 
and Tapio Nevalainen 


NOVEL OXADIAZOLONE ANALOGUES 
AS FAAH AND/OR MGL INHIBITORS 


P3-21 


Mariateresa Cipriano, Jonas 
Eriksson, Emmelie Bjorklund, 

Alka Marwaha, Anders 
Lindgren, Per-Anders Enquist, 
Mikael Elofsson 
and Christopher J. Fowler 


NOVEL INHIBITORS OF MONOACYLGLYCEROL LIPASE 


P3-22 


Mauro Maccarrone, Almerinda 
Di Venere, Enrico Dainese, 
Filomena Fezza, Beatrice Clotilde 

Angelucci, Nicola Rosato, 
Benjamin F. Cravatt, Alessandro 
Finazzi-Agro and Giampiero Mei 


HIDDEN DIFFERENCES BETWEEN RAT AND 
HUMAN FATTY ACID AMIDE HYDROLASES 


P3-23 


Redmond W.J., Gu L., 
Mclntyre P. and Connor M 


DETERMINANTS OF FATTY ACID ACTIVATION OF 
THE PRONOCICEPTIVE ION CHANNEL TRPA1 


P3-24 


Ulrike Thieme, Matthias 
Feuerecker, Daniela Hauer, Alex 
Salam, Detlef Thieme, Alexander 
Chouker and Gustav Schelling 


CHANGES IN CIRCULATING ENDOCANNABINOIDS 
AND N-ACYLETHANOLAMINES DURING 
OVERWINTERING AT CONCORIA RESEARCH 
STATION IN CONTINENTAL ANTARCTICA 


P3-25 


Cyrill Hornuss, Daniela Hauer, 
Patrizia Campolongo, Isabel 
Briegel, Christian C. Apfel 
and Gustav Schelling 


GENERAL ANESTHESIA WITH PROPOFOL INFLUENCES 

CIRCULATING ENDOCANNABINOIDS AND 
N-ACYLETHANOLAMINES: A STUDY IN VOLUNTEERS 


P3-26 


Kazuhito Tsuboi, Yumiko 
Yamano, Yuki Hozaki, Kiyohiro 

Takahashi, Xing-Hua Jin, 
Akimori Wada and Natsuo Ueda 


LIPOPHILIC AMINES AS INHIBITORS OF 
N-ACYLETHANOLAMINE-HYDROLYZING ACID 
AMIDASE (NAAA) 


P3-27 


Kazuhito Tsuboi, Yasuo 
Okamoto, Natsuki Ikematsu, 
Manami Inoue, 
Yoshibumi Shimizu, Toru 
Uyama, Dale G. Deutsch, 
Akira Tokumura, 
and Natsuo Ueda 


BIOSYNTHETIC PATHWAYS OF 
N-ACYLETHANOLAMINES FROM 
N-ACYLATED PLASMALOGEN PHOSPHOLIPID 


P3-28 



Michiel G.J. Balvers, 
Renger F. Witkamp 
and Kitty CM. Verhoeckx 


FREE AND ESTERIFIED N-ACYL ETHANOLAMINES 

IN PLASMA AND BLOOD CELLS: EVIDENCE FOR 
PREVIOUSLY IGNORED POOLS OF ESTERIFIED NAEs 


P3-29 


A. Martella, C. Silvestri, 
O. Carnevali and V. Di Marzo 


CHARACTERIZATION OF THE ENDOCANNABINOID 
SYSTEM DURING ZEBRAFISH (DANIO RERIO) 
EMBRYOGENESIS AND POSSIBLE DRUG 
SCREENING APPLICATIONS 


P3-30 


Niina Aaltonen, Casandra Riera 
Ribas, Marko Lehtonen, 
Juha Savinainen 
and Jarmo T. Laitinen 


BRAIN REGIONAL CANNABINOID CB1 RECEPTOR 
SIGNALLING AND ALTERNATIVE ENZYMATIC 
PATHWAYS FOR 2-ARACHIDONOYLGLYCEROL 
GENERATION IN BRAIN SECTIONS OF DAGL-ALPHA 
AND DAGL-BETA DEFICIENT MICE 


P3-31 


Rebecca Henry, Daniel Kerr, 
David P. Finn 
and Michelle Roche 


TLR-3 MEDIATED CYTOKINE EXPRESSION IN THE 
RAT HIPPOCAMPUS IS ALTERED FOLLOWING 
PHARMACOLOGICAL INHIBITION OF FAAH 


P3-32 


Collin B. Merrill, Michael 
McNeil, Ryan C. Williamson 
and Jeffrey G. Edwards 


IDENTIFICATION OF MRNA FOR ENDOCANNABINOID 
BIOSYNTHETIC ENZYMES WITHIN HIPPOCAMPAL 
PYRAMIDAL CELLS AND CA1 STRATUM RADIATUM 

TTV ITFTl TV TFT ' 1 1 /""*v N T f T TTT~P"\ /Til - ' C T TCTTV T / — > /~~\T T A TV ITTT A TTT f F 

INTERNEURON SUBTYPES USING QUANTITATIVE 
REAL-TIME PCR 


P3-33 


Carina E. P. Kozmus, Vojko 
Berce and Uros Potocnik 


CNR2 AND ABHD4 GENE EXPRESSION IS 
UP-REGULATED IN ASTHMA PATIENTS 


P3-34 


Alex Straiker, Sherry Shu-jung 
Hu, Jacqueline Blankman, 
Benjamin F. Cravatt 
and Ken Mackie 


DISTRIBUTION OF ABHD12 PROTEIN IN MURINE BRAIN 


P3-35 


Elizabeth Sabens Liedhegner, 
Kara Stuhr and Cecilia Hillard 


REGULATION OF ENDOCANNABINOID 
LEVELS BY STEROL CARRIER PROTEIN 2 


P3-36 


TOPIC J. PAIN 


Miriam Schneider, Peggy 
Schneider, Christian Schmahl, 
Rainer Spanagel 
and Martin Bohus 


SOCIAL PAIN AND THE ENDOCANNABINOID SYSTEM: 
ADOLESCENT PEER-REJECTION PERSISTENTLY 
ALTERS PAIN PERCEPTION AND CB1 RECEPTOR 
EXPRESSION IN FEMALE RATS 


P3-37 


Jordyn M. Stuart, Julie Wiesler, 
Amanda Ellis, Linda Watkins, 
and Heather B. Bradshaw 


ENDOGENOUS CANNABINOIDS AND RELATED N-ACYL 
AMIDES ARE UP AND DOWN-REGULATED IN A SPINAL 
CORD INJURY MODEL OF NEUROPATHIC PAIN 


P3-38 


Brandon P Rhodes, Jordyn M. 
Stuart, Siham Raboune 
and Heather B. Bradshaw 


LEVELS OF ENDOCANNABINOIDS AND RELATED 
N-ACYL AMIDES CHANGE IN THE CEREBELLUM, 
MIDBRAIN, BRAINSTEM AND THALAMUS IN A MODEL 
OF ACUTE PERIPHERAL INFLAMMATION 


P3-39 



Sara M. Takacs, Jordyn M. Stuart, 
Siham Raboune 
and Heather B. Bradshaw 


PERIPHERAL INFLAMMATION DRIVES CHANGES IN 
N-ACYL AMIDES IN THE STRIATUM AND HIPPOCAMPUS 


P3-40 


Neil J. Poloso, Jenny W. Wang, 
Elaine Tang 
and David F. Woodward 


CHARACTERIZATION OF A MODEL OF 
OCULAR PAIN/DISCOMFORT WITH RESPECT 
TO CYCLO-OXYGENASE AND PROSTANOID 
RFCFPTOR TNVOT VFMFNT 

1 \ 1—/ v^. I_, 1 J. v_y l\ V V/Li V I_j1V1I_j1\ _L 


P3-41 


V.S. Seybold, L.G. Coicou, 
D. Piomelli and LA. Khasabova 


ACTIVATION OF PPARa IN DORSAL ROOT 
GANGLION NEURONS MODULATES NOCICEPTION 
AND REDUCES TUMOR PAIN IN MICE 


P3-42 


Natalia Malek, Michal 
Korostynski, Barbara Przewlocka 
and Katarzyna Starowicz 


NERVE INJURY-INDUCED MOLECULAR CHANGES: 
ROLE OF THE ENDOCANNABINOID 
AND ENDOVANILLOID SYSTEMS 


P3-43 


Sara Jane Ward, 
Sean D. McAllister, 
Harshini Neelakantan 
and Ellen A. Walker 


PACLIT AXEL-INDUCED NEUROTOXICITY: 
EFFICACY AND SAFETY OF CANNABIDIOL 
AS A NOVEL TREATMENT STRATEGY 


P3-44 


Liting Deng, Josee Guindon, Ken 
Mackie, Fletcher White, Ganesh 
Thakur, Alexandras Makriyannis 
and Andrea G. Hohmann 


SELECTIVE ACTIVATION OF CANNABINOID 
CB2 RECEPTORS SUPPRESSES CHEMOTHERAPY- 
INDUCED NEUROPATHY INDEPENDENT OF 
CB1 OR CXCR4 RECEPTOR SIGNALING 


P3-45 


Weredeselam M. Olango, 
Michelle Roche 
and David P. Finn 


PHARMACOLOGICAL MODULATION OF THE 
ENDOCANNABINOID SYSTEM IN TWO RAT STRAINS 
DIFFERING IN NOCICEPTIVE RESPONSIVITY: 
BEHAVIOURAL EFFECTS AND RVM ZIF268 EXPRESSION 


P3-46 


Bright Okine, Weredeselam M. 
Olango, Brendan Harhen, 
Michelle Roche 
and David P. Finn 


CHARACTERISATION OF THE 
ENDOCANNABINOID SYSTEM WITHIN THE 
DESCENDING PAIN PATHWAY OF TWO RAT 
STRAINS DIFFERING IN NOCICEPTIVE RESPONSIVITY 


P3-47 


Padmanabha V. Kattamuri, 
Rebecca Salmonsen, Catherine 
McQuain, Sumner Burstein 
and Guigen Li 


ASYMMETRIC SYNTHESIS OF NOVEL N-(l-PHENYL-2,3- 
DIHYDROXYPROPYL) ARACHIDONYLAMIDES 
AND EVALUATION OF THEIR ANTI- 
INFLAMMATORY ACTIVITY 


P3-48 


Ermelinda Lomazzo, Raissa 
Lerner, Claudia Schwitter 
and Beat Lutz 


THE ENDOCANNABINOID SYSTEM AND 
STRESS-MEDIATED ENHANCEMENT OF 
PAIN SUSCEPTIBILITY IN MICE 


P3-49 


Enza Palazzo, Vito de Novellis, 
Livio Luongo, Francesca Guida, 
and Sabatino Maione 


INTERACTION BETWEEN CANNABINOID AND 
METABOTROPIC GLUTAMATE RECEPTORS IN THE 
PERIAQUEDUCTAL GRAY-ROSTRAL VENTROMEDIAL 
MEDULLA PATHWAY IN NEUROPATHIC RAT 


P3-50 


Sudeshna Ghosh, Laura E. Wise, 
Rehab A. Abdulla, Micah J. 
Niphakis, Benjamin F. Cravatt 
and Aron H. Lichtman 


COMBINED INHIBITION OF MAGL AND 
FAAH SUPPRESSES EDEMA AND PRODUCES 
AUGMENTED ANTI-ALLODYNIC EFFECTS 
IN THE CARRAGEEN AN MOUSE MODEL 


P3-51